Mankind Pharma - MANKIND, 543904 corporate action history

Mankind Pharma Ltd. NSE: MANKIND | BSE: 543904

Expensive Underperformer

In 2 Starfolio Baskets

Download real time

2060.20 -20.20 (-0.97%)

New 52W Low today

362.5K

NSE+BSE Volume

NSE 06 Feb, 2026 3:31 PM (IST)

Rising Revenue

Mankind Pharma’s Q3 revenue grows 10.5% YoY, driven by strong demand for chronic therapies See details

Mankind Pharma Bonus history

Mankind Pharma has not announced any bonus since Jan 1, 2000.

See all forthcoming Bonus and Splits

Mankind Pharma Split history

Mankind Pharma has not split the face value of the share since Jan 1, 2000.

See all forthcoming Bonus and Splits

Dividend history for Mankind Pharma

Mankind Pharma has declared 1 dividend since Aug. 8, 2025.

In the past 12 months, Mankind Pharma has declared an equity dividend amounting to ₹1.00 per share.

At the current share price of ₹2060.2000, Mankind Pharma's dividend yield is 0.05%.

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
08 Aug 2025	1.00	INTERIM	08 Aug 2025	Equity Share

See all forthcoming dividends Check out stocks with top dividend.

Board Meetings - Mankind Pharma

The latest board meeting for Mankind Pharma took place on 03 Feb 2026, for the purpose of Quarterly Results

Ex-Date	Purpose	Notes
03 Feb 2026	Quarterly Results	-
06 Nov 2025	Quarterly Results	-
31 Jul 2025	Quarterly Results & Interim Dividend	-
21 May 2025	Audited Results	-
23 Jan 2025	Quarterly Results	-
05 Nov 2024	Quarterly Results	-
31 Jul 2024	Quarterly Results	-
15 May 2024	Audited Results & Others	To evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.
31 Jan 2024	Quarterly Results	-
31 Oct 2023	Quarterly Results	-

See all Board Meetings for Mankind Pharma

Mankind Pharma Rights history

Mankind Pharma has not issued any rights since Jan 1, 2000.

See all Rights History for Mankind Pharma